Delivery Order SPE2DB20D3101-SPE2DB23FRRM8
Award Date
7/11/23
Potential Completion Date
7/12/23
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.36, is a Firm Fixed Price Delivery Order for the supply of "COCAINE 160 MG/4 ML NASAL SOLN 4ML" medical products. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,878.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4% nasal solution of cocaine hydrochloride. The contract is a delivery order type, with a firm fixed price, and has an ultimate completion date of June 7, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.94 firm fixed-price delivery order is for the supply of Cocaine 160 mg/4 ml Nasal Solution, 4 ml, with an ultimate completion date of October 28, 2024. The award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4% cocaine hydrochloride nasal solution (4 mL) to support military healthcare programs. The contract has a ceiling value of $3,734.96 and a completion date of February 3, 2025. It is a firm-fixed-price contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $42,187.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under the DLA's Indefinite Delivery Contract (IDC) for pharmaceutical products and medical supplies, valued at up to $999,999,999.00 and running through November 2026. The award covers a broad range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of pharmaceutical products and medical supplies. The award, valued at $1,135.62, is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen's parent company, Cencora, Inc. This IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award, valued at $1,653.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award, valued at $1,067.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for pharmaceutical and medical supplies to support the DLA Troop Support Medical program, which provides healthcare products to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers a broad range of medical commodities,...
This federal contract award, valued at $12,577.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products and medical supplies. The award, valued at $1,672.41, is a delivery order contract with a firm-fixed-price pricing type. The contract does not have a set-aside designation. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support...